HN804a : Head and neck cancer tissue array with normal tongue tissues, including pathology grade, TNM and clinical stage (AJCC 8.0), 79 cases/79 cores (core size 1.5mm), replacing HN804
|
Microarray Panel | Head and neck cancer with tongue tissue microarray, containing 57 squamous cell carcinoma, 3 undifferentiated carcinoma, 1 sarcomatoid carcinoma, 8 metastatic squamous cell carcinoma, 7 tongue tissue, 2 salivary gland tissuem, 1 each of sublingual gland tissue and parotid gland tissue, single core per case | |
Cores | 80 | |
Cases | 79 | |
Row number | 8 | |
Column number | 10 | |
Core Diameter (mm) | 1 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Bla - Blank,
Cav - Cavioris bucca,
Epi - Epiglottis,
Hyp - Hypopharynx,
Lar - Larynx,
Low - Lower lip,
Lym - Lymph node,
Max - Maxillary sinus,
Mou - Mouth floor,
Nos - Nose,
Pal - Palate,
Par - Parotid gland,
Pha - Pharynx/oropharynx,
Sal - Salivary gland,
Sof - Soft palate,
Sub - Sublingual gland,
Ton - Tongue,
Upp - Upper jaw
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 74 | M | Nose | Squamous cell carcinoma of nasal septum | T2N0M0 | 1 | II | Malignant | |
A2 | 2 | 42 | F | Nose | Squamous cell carcinoma of nasal cavity | T1N0M0 | 1 | I | Malignant | |
A3 | 3 | 40 | M | Nose | Squamous cell carcinoma of nasal cavity | T2N0M0 | 1 | II | Malignant | |
A4 | 4 | 71 | M | Nose | Squamous cell carcinoma of nasal cavity | T2N0M0 | 2 | II | Malignant | |
A5 | 5 | 30 | M | Nose | Squamous cell carcinoma of nasal cavity | T1N0M0 | 2 | I | Malignant | |
A6 | 6 | 50 | M | Nose | Squamous cell carcinoma of nasopharynx | T2N0M0 | 2 | II | Malignant | |
A7 | 7 | 40 | M | Nose | Squamous cell carcinoma of nasal cavity | T1N0M0 | 2 | I | Malignant | |
A8 | 8 | 74 | M | Nose | Squamous cell carcinoma of root of nose | T2N0M0 | 2 | II | Malignant | |
A9 | 9 | 45 | M | Nose | Undifferentiated carcinoma of sinus | T3N0M0 | - | III | Malignant | |
A10 | 10 | 75 | F | Upper jaw | Squamous cell carcinoma | T1N0M0 | 1 | I | Malignant | |
B1 | 11 | 50 | M | Maxillary sinus | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
B2 | 12 | 46 | F | Maxillary sinus | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
B3 | 13 | 57 | M | Maxillary sinus | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
B4 | 14 | 53 | M | Maxillary sinus | Squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
B5 | 15 | 51 | M | Maxillary sinus | Squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
B6 | 16 | 51 | F | Maxillary sinus | Squamous cell carcinoma with neuroendocrine differentiation | T2N0M0 | 3 | II | Malignant | |
B7 | 17 | 75 | M | Maxillary sinus | Undifferentiated carcinoma | T3N0M0 | - | III | Malignant | |
B8 | 18 | 72 | F | Soft palate | Squamous cell carcinoma (tonsil tissue) | T2N0M0 | 1 | II | Malignant | |
B9 | 19 | 61 | M | Soft palate | Squamous cell carcinoma (sparse) | T2N0M0 | 2 | II | Malignant | |
B10 | 20 | 67 | M | Palate | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
C1 | 21 | 61 | F | Palate | Squamous cell carcinoma | T1N0M0 | 1 | I | Malignant | |
C2 | 22 | 31 | M | Mouth floor | Squamous cell carcinoma | T1N0M0 | 1 | I | Malignant | |
C3 | 23 | 48 | M | Lower lip | Squamous cell carcinoma | T1N0M0 | 1 | I | Malignant | |
C4 | 24 | 45 | M | Tongue | Squamous cell carcinoma | T4N1M0 | 1 | IV | Malignant | |
C5 | 25 | 48 | M | Tongue | Squamous cell carcinoma | T3N0M0 | 1 | III | Malignant | |
C6 | 26 | 55 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
C7 | 27 | 60 | F | Tongue | Squamous cell carcinoma | T2N0M0 | 1 | II | Malignant | |
C8 | 28 | 46 | F | Tongue | Squamous cell carcinoma | T4aN0M0 | 1 | IVA | Malignant | |
C9 | 29 | 37 | M | Tongue | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
C10 | 30 | 53 | M | Lower lip | Squamous cell carcinoma | T1N1M0 | 3 | IV | Malignant | |
D1 | 31 | 52 | M | Cavioris bucca | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
D2 | 32 | 50 | M | Parotid gland | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
D3 | 33 | 76 | M | Parotid gland | Squamous cell carcinoma | T3N0M0 | 3 | III | Malignant | |
D4 | 34 | 61 | F | Parotid gland | Squamous cell carcinoma | T2N1M0 | 3 | III | Malignant | |
D5 | 35 | 55 | M | Epiglottis | Squamous cell carcinoma | T4N0M0 | 1 | IV | Malignant | |
D6 | 36 | 50 | F | Hypopharynx | Squamous cell carcinoma | T2N1M0 | 1 | III | Malignant | |
D7 | 37 | 51 | M | Pharynx/oropharynx | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
D8 | 38 | 54 | M | Pharynx/oropharynx | Squamous cell carcinoma | T3N0M0 | 2 | III | Malignant | |
D9 | 39 | 61 | M | Epiglottis | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
D10 | 40 | 66 | M | Pharynx/hypopharynx | Squamous cell carcinoma | T3N2M0 | 2 | IVA | Malignant | |
E1 | 41 | 71 | M | Epiglottis | Squamous cell carcinoma | T3N1M0 | 2 | III | Malignant | |
E2 | 42 | 44 | M | Hypopharynx | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
E3 | 43 | 61 | M | Epiglottis | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
E4 | 44 | 61 | M | Hypopharynx | Squamous cell carcinoma | T3N0M0 | 2 | II | Malignant | |
E5 | 45 | 63 | M | Pharynx/hypopharynx | Squamous cell carcinoma (cartilage tissue) | T3N1M0 | 2 | III | Malignant | |
E6 | 46 | 67 | M | Pharynx/hypopharynx | Squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
E7 | 47 | 48 | M | Pharynx/hypopharynx | Squamous cell carcinoma | T4aN0M0 | 3 | IVA | Malignant | |
E8 | 48 | 75 | M | Pharynx/oropharynx | Basal cell squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
E9 | 49 | 47 | M | Larynx | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
E10 | 50 | 57 | M | Larynx | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | |
F1 | 51 | 56 | M | Larynx | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
F2 | 52 | 67 | M | Larynx | Squamous cell carcinoma | T3N1M0 | 2 | III | Malignant | |
F3 | 53 | 55 | M | Larynx | Squamous cell carcinoma | T3N1M0 | 2 | III | Malignant | |
F4 | 54 | 58 | M | Larynx | Squamous cell carcinoma | T3N1M1 | 2 | IV | Malignant | |
F5 | 55 | 47 | M | Larynx | Squamous cell carcinoma | T2N1M0 | 2 | III | Malignant | |
F6 | 56 | 49 | M | Larynx | Squamous cell carcinoma | T4aN0M0 | 2 | IVA | Malignant | |
F7 | 57 | 49 | M | Larynx | Squamous cell carcinoma | T2N1M0 | 3 | III | Malignant | |
F8 | 58 | 50 | M | Larynx | Squamous cell carcinoma | T3N1M0 | 3 | III | Malignant | |
F9 | 59 | 65 | M | Larynx | Squamous cell carcinoma | T4aN1M0 | 3 | IVA | Malignant | |
F10 | 60 | 64 | M | Larynx | Squamous cell carcinoma | T2N0M0 | 3 | II | Malignant | |
G1 | 61 | 32 | F | Maxillary sinus | Sarcomatoid carcinoma | T2N0M0 | - | II | Malignant | |
G2 | 62 | 58 | M | Lymph node | Metastatic squamous cell carcinoma of lower jaw | - | 1 | - | Metastasis | |
G3 | 63 | 60 | M | Lymph node | Metastatic squamous cell carcinoma of lower jaw | - | 1 | - | Metastasis | |
G4 | 64 | 43 | M | Lymph node | Metastatic squamous cell carcinoma of lower jaw | - | 1 | - | Metastasis | |
G5 | 65 | 45 | F | Lymph node | Metastatic squamous cell carcinoma of neck | - | 2 | - | Metastasis | |
G6 | 66 | 48 | M | Lymph node | Metastatic squamous cell carcinoma of neck | - | 2 | - | Metastasis | |
G7 | 67 | 53 | M | Lymph node | Metastatic squamous cell carcinoma of neck | - | 2 | - | Metastasis | |
G8 | 68 | 71 | M | Lymph node | Metastatic squamous cell carcinoma of piriform fossa | - | 2 | - | Metastasis | |
G9 | 69 | 40 | F | Lymph node | Metastatic squamous cell carcinoma of neck | - | 2 | - | Metastasis | |
G10 | 70 | 27 | F | Tongue | Tongue tissue | - | - | - | Normal | |
H1 | 71 | 18 | F | Tongue | Tongue tissue | - | - | - | Normal | |
H2 | 72 | 35 | M | Tongue | Tongue tissue | - | - | - | Normal | |
H3 | 73 | 19 | F | Tongue | Tongue tissue | - | - | - | Normal | |
H4 | 74 | 28 | M | Tongue | Tongue tissue | - | - | - | Normal | |
H5 | 75 | 15 | F | Tongue | Tongue tissue | - | - | - | Normal | |
H6 | 76 | 48 | M | Tongue | Tongue tissue | - | - | - | Normal | |
H7 | 77 | 19 | F | Sublingual gland | Sublingual gland tissue | - | - | - | Normal | |
H8 | 78 | 28 | M | Parotid gland | Parotid gland tissue | - | - | - | Normal | |
H9 | 79 | 50 | M | Salivary gland | Salivary gland tissue | - | - | - | Normal | |
H10 | 80 | - | = | Blank | - | - | - | - | - |
Find overlapping cases with this tissue array:
- Product Code: HN804a
- Availability: In Stock